4 Results for "

339324

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "339324" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-50751
CAS No.: 796967-16-3
Synonyms: ABT-869; AL-39324
Research Areas:  

Cancer

Linifanib (ABT-869) is a potent and orally active multi-target inhibitor of VEGFR and PDGFR family with IC50s of 4, 3, 66, and 4 nM for KDR, FLT1, PDGFRβ, and FLT3, respectively. Linifanib shows prominent antitumor activity. Linifanib has much less activity against unrelated RTKs, soluble tyrosine kinases, or serine/threonine kinases. Linifanib is a specific miR-10b inhibitor that blocks miR-10b biogenesis .
loading...
    loading...
Cat. No.: HY-50751G
CAS No.: 796967-16-3
Synonyms: ABT-869 (GMP); AL-39324 (GMP)
Linifanib (ABT-869) (GMP) is Linifanib (HY-50751) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Linifanib is a potent and orally active multi-target inhibitor of VEGFR and PDGFR family with IC50s of 4, 3, 66, and 4 nM for KDR, FLT1, PDGFRβ, and FLT3, respectively. Linifanib (GMP) promotes the generation and reprogramming of iPSCs from somatic cells .
loading...
    loading...
Cat. No.: HY-50751R
CAS No.: 796967-16-3
Synonyms: ABT-869 (Standard); AL-39324 (Standard)
Linifanib (Standard) is the analytical standard of Linifanib. This product is intended for research and analytical applications. Linifanib (ABT-869) is a potent and orally active multi-target inhibitor of VEGFR and PDGFR family with IC50s of 4, 3, 66, and 4 nM for KDR, FLT1, PDGFRβ, and FLT3, respectively. Linifanib shows prominent antitumor activity. Linifanib has much less activity against unrelated RTKs, soluble tyrosine kinases, or serine/threonine kinases. Linifanib is a specific miR-10b inhibitor that blocks miR-10b biogenesis .
loading...
    loading...
Cat. No.: HY-50751S
Synonyms: ABT-869-d4; AL-39324-d4
Linifanib-d4 (ABT-869-d4; AL-39324-d4) is deuterium-labeled Linifanib (HY-50751) .
loading...
    loading...